Support surfaces have been used for many years to treat or prevent pressure ulcers. In early 1996, the availability, application, and reimbursement for use of these products in the home care setting changed dramatically with the implementation of a new Medicare Part B “Medical Policy for Support Surfaces.” This article reviews definitions and characteristics of the products as outlined in this policy, clinical criteria for patient qualification, and documentation requirements. Products assigned to Group 2 of the Medical Policy (those designed to treat patients with advanced stage wounds) are emphasized. Additional issues concerning billing, product selection based on patient need, environmental factors, and related financial implications are also presented.
Reprints not available from the authors.
Copyright © 1998 by the Wound, Ostomy and Continence Nurses Society